Ctxr offering
WebAug 5, 2024 · CRANFORD, N.J., Aug. 5, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR ), a specialty pharmaceutical company … WebApr 10, 2024 · My projections anticipate that CTXR will raise $50 million in an equity offering in 23Q4 at a price of $1.20 per share. I anticipate I/ONTAK revenues of $15 million in 2024, which is 3.75%-5.00% of the estimated addressable market of $300-$400 million.
Ctxr offering
Did you know?
WebFeb 17, 2024 · Citius Pharmaceuticals (CTXR) Prices 50.83M Share Registered Direct Offering at $1.505/Sh Article Related Press Releases ( 1 ) Stock Quotes (1) FREE … WebFeb 17, 2024 · Citius Pharmaceuticals Announces $76.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules News provided by Citius Pharmaceuticals, Inc.
WebApr 11, 2024 · About Citius Pharmaceuticals (NASDAQ:CTXR) Stock Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. WebWhat is CTXR's Price Target? According to 1Wall Street analystthat have issued a 1 year CTXRprice target, the average CTXRprice target is $6.00, with the highest CTXR stock …
WebApr 9, 2024 · The S&P 500 ticked slightly higher Monday as investors looked ahead to key inflation data this week. The broader index rose 0.1% to 4,109.11. The Dow Jones Industrial Average added 101.23 points ... WebCTXR Citius Pharmaceuticals Inc 21,868 Watch Alerts Buy $1.37 $0.06 (4.58%) Today $1.37 0.00 (0.00%) Pre-Market Market Cap $200.37M Volume (M) 22.00 52-Wk High …
WebMay 7, 2024 · Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) is a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on...
WebView the basic CTXR option chain and compare options of Citius Pharmaceuticals, Inc. on Yahoo Finance. patco air conditioning mobile alWeb6.67R USD +5.57 +506.06% The 3 analysts offering 1 year price forecasts for Citius Pharmaceuticals, Inc. have a max estimate of 10.00 and a min estimate of 4.00. Analyst rating Based on 3 analysts giving stock ratings to Citius Pharmaceuticals, Inc. in the past 3 months. Neutral Sell Buy Strong sell Strong buy Strong buy Strong buy 3 Buy 0 Hold 0 patco air conditionerWebFeb 19, 2024 · It was founded in 2010 and joined the public market via an initial public offering (IPO) in September 2014. ... N.J. CTXR stock was up 23.8% as of Friday … カウネット工房 封筒Web18 hours ago · View Citius Pharmaceuticals, Inc CTXR investment & stock information. Get the latest Citius Pharmaceuticals, Inc CTXR detailed stock quotes, stock data, Real-Time … かうねっと工房 返品Web$CTXR Offering Walrus did a DD on this yesterday, the stock was near $2 when the offering hit at 1.50. Please watch The WalrusStreets DD - … カウネット 法人 カタログWebCTXR Stock 12 Months Forecast. $5.00. (327.35% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Citius Pharmaceuticals in the last 3 months. The … patco alvin txWebCTXR 2M Long Term test Citius Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives … patco angle grinder